Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec 27;5(12):666-75.
doi: 10.4254/wjh.v5.i12.666.

Life cycle and pathogenesis of hepatitis D virus: A review

Zaigham Abbas  1 , Rafia Afzal  1
Affiliations
Review

Life cycle and pathogenesis of hepatitis D virus: A review

Zaigham Abbas et al. World J Hepatol. .

Abstract

Hepatitis D virus (HDV) is a defective RNA virus which requires the help of hepatitis B virus (HBV) virus for its replication and assembly of new virions. HDV genome contains only one actively transcribed open reading frame which encodes for two isoforms of hepatitis delta antigen. Post-translational modifications of small and large delta antigens (S-HDAg and L-HDAg) involving phosphorylation and isoprenylation respectively confer these antigens their specific properties. S-HDAg is required for the initiation of the viral genome replication, whereas L-HDAg serves as a principal inhibitor of replication and is essential for the assembly of new virion particles. Immune mediation has usually been implicated in HDV-associated liver damage. The pathogenesis of HDV mainly involves interferon-α signaling inhibition, HDV-specific T-lymphocyte activation and cytokine responses, and tumor necrosis factor-alpha and nuclear factor kappa B signaling. Due to limited protein coding capacity, HDV makes use of host cellular proteins to accomplish their life cycle processes, including transcription, replication, post-transcriptional and translational modifications. This intimate host-pathogen interaction significantly alters cell proteome and is associated with an augmented expression of pro-inflammatory, growth and anti-apoptotic factors which explains severe necroinflammation and increased cell survival and an early progression to hepatocellular carcinoma in HDV patients. The understanding of the process of viral replication, HBV-HDV interactions, and etio-pathogenesis of the severe course of HDV infection is helpful in identifying the potential therapeutic targets in the virus life cycle for the prophylaxis and treatment of HDV infection and complications.

Keywords: Hepatitis B virus; Hepatitis D virus; Hepatitis D virus pathogenicity; Hepatitis delta antigens; Hepatocellular carcinoma; Host-pathogen interactions; Interferon-alpha; Virus replication.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hepatitis D virus replication cycle. HBV: Hepatitis B virus; HDV: Hepatitis D virus.
Figure 2
Figure 2
Depicts hepatitis D virus pathogenesis. HDV: Hepatitis D virus; IL: Interleukin; IFN: Involves interferon.
Figure 3
Figure 3
Interferon-α signaling and inhibition by hepatitis D virus. HDV: Hepatitis D virus; INF: Interferon; STAT: Signal transducer and activator of transcription; JAK: Janus kinase; IRF9: Interferon regulatory factor 9; ISGF3: INF-stimulated gene factor 3; ISG: INF stimulated genes; ISRE: INF-stimulated response elements; P: Phosphorylated residues.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lin JH, Chang MF, Baker SC, Govindarajan S, Lai MM. Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol. 1990;64:4051–4058. - PMC - PubMed
    1. Abbas Z, Jafri W, Raza S. Hepatitis D: Scenario in the Asia-Pacific region. World J Gastroenterol. 2010;16:554–562. - PMC - PubMed
    1. Wang CJ, Chen PJ, Wu JC, Patel D, Chen DS. Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles. J Virol. 1991;65:6630–6636. - PMC - PubMed
    1. Lai MM. Molecular biologic and pathogenetic analysis of hepatitis delta virus. J Hepatol. 1995;22:127–131. - PubMed
    1. Casaca A, Fardilha M, da Cruz e Silva E, Cunha C. The heterogeneous ribonuclear protein C interacts with the hepatitis delta virus small antigen. Virol J. 2011;8:358. - PMC - PubMed